4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Praxis Precision Medicines, Inc. (PRAX) operates in the Biotechnology industry and is headquartered in Boston, United States with about 168 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, PRAX reported $0M in revenue and ($303M) in net income.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $9M | $2M | $0M | — |
| Operating Income (EBIT) | ($326M) | ($200M) | ($126M) | ($215M) | — |
| Net Income | ($303M) | ($183M) | ($123M) | ($214M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($106M) | ($97M) | ($78M) | ($76M) | ($75M) |
| Net Income | ($93M) | ($89M) | ($74M) | ($71M) | ($69M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $938M | $483M | $88M | $115M | — |
| Total Liabilities | $60M | $38M | $18M | $39M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRAX viewer.
About TickerBase · Data methodology & sources